Medline Inc.
NASDAQMDLN drops its Q1 2026 results on May 8 carrying a 7% one-day loss, a pile of private equity selling, and options positioning that has shifted notably more defensive. The session before the print told a stark story. Shares fell 7.3% on May 6 to close at $42.01, extending a 3.2% slide on the week and a 5.1% pullback over the past month. That one-day move is the kind of dislocated…
Snapshot as of 7 May 2026
MDLN drops its Q1 2026 results on May 8 carrying a 7% one-day loss, a pile of private equity selling, and options positioning that has shifted notably more defensive. The session before the print told a stark story.…
MDLN delivered a clean Q1 beat this morning — EPS of $0.33 against a $0.23 estimate, and revenue of $7.4 billion clearing the $7.16 billion consensus — yet the same day brought a potentially more disruptive headline:…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MDLN — free to start on ORTEX.
Sign up for free →Open MDLN on ORTEX